F.Biotechnology Dis.Fd.A-H1 EUR H
LU1803069274
F.Biotechnology Dis.Fd.A-H1 EUR H/ LU1803069274 /
NAV10/9/2024 |
Chg.-0.0400 |
Type of yield |
Investment Focus |
Investment company |
12.5800EUR |
-0.32% |
reinvestment |
Equity
Worldwide
|
Franklin Templeton ▶ |
Investment goal
The Fund aims to capital appreciation by investing principally in equity securities of biotechnology companies and discovery research firms mainly located in the US.
Master data
Type of yield: |
reinvestment |
Funds Category: |
Equity |
Region: |
Worldwide |
Branch: |
Sector Biotechnology |
Benchmark: |
NASDAQ Biotechnology Index |
Business year start: |
7/1 |
Last Distribution: |
- |
Depository bank: |
J.P. Morgan SE, Niederlassung Luxemburg |
Fund domicile: |
Luxembourg |
Distribution permission: |
Austria, Germany, Switzerland, Luxembourg, Czech Republic |
Fund manager: |
Evan McCulloch, Akiva Felt |
Fund volume: |
1.59 bill.
USD
|
Launch date: |
4/6/2018 |
Investment focus: |
- |
Conditions
Issue surcharge: |
5.75% |
Max. Administration Fee: |
1.50% |
Minimum investment: |
1,000.00 EUR |
Deposit fees: |
0.14% |
Redemption charge: |
0.00% |
Key Investor Information: |
Download (Print version) |
Investment company
Funds company: |
Franklin Templeton |
Address: |
Schottenring 16, 2.OG, 1010, Wien |
Country: |
Austria |
Internet: |
www.franklintempleton.at
|
Assets
Stocks |
|
95.02% |
Bonds |
|
1.75% |
Others |
|
3.23% |
Countries
United States of America |
|
78.73% |
Netherlands |
|
5.50% |
United Kingdom |
|
3.75% |
Denmark |
|
3.48% |
Ireland |
|
2.65% |
France |
|
0.90% |
Cayman Islands |
|
0.74% |
Canada |
|
0.70% |
Germany |
|
0.33% |
Others |
|
3.22% |
Branches
Pharma/Biotechnology |
|
90.92% |
Healthcare services |
|
4.10% |
Others |
|
4.98% |